The pharma has sought shareholders approval to raise up to Rs. 12,000 crore through convertible debentures or QIP for business expansion and acquisitions.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
The pharma has sought shareholders approval to raise up to Rs. 12,000 crore through convertible debentures or QIP for business expansion and acquisitions.
| Subscribe To Our Free Newsletter |
